Genestra Brands

Glucosamine Complex

C+
N+ Score76
Joint & BoneServing: 2 Capsule(s)Type: Other Combinations

Glucosamine Complex is an 'Other Combinations' supplement designed for joint and bone health, receiving an N+ Score of 76 and a 'C+' grade, indicating a good quality product. This supplement contains 9 ingredients, offering a broad spectrum of compounds commonly associated with joint support. However, none of the individual ingredients, including Glucosamine Sulfate (750mg), MSM (150mg), or Chondroitin Sulfate (50mg), are present at clinically studied dosages based on the provided data. This product may appeal to individuals seeking a multi-ingredient approach to joint support, but dosages should be considered.

About This Product

Glucosamine Complex by Genestra Brands is a joint & bone supplement containing 9 active ingredients. It has earned an N+ Score of 76/100 (Grade C+).

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness75/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity100/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Comprehensive formula with expected ingredients for its category
  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms

Weaknesses

  • −No major weaknesses identified

Ingredient Analysis (9 ingredients)

IngredientAmountDose Adequacy
Bromelain16.600 mgN/A
Chondroitin Sulfate50.000 mgN/A
Glucosamine Sulfate750.000 mgN/A
Rutin10.000 mgN/A
L-Cysteine50.000 mgN/A
L-Proline50.000 mgN/A
MSM150.000 mgN/A
Hesperidin50.000 mgN/A
Green Tea (Camellia sinensis) leaf std. extract40.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.